CRINEPT-TROSY NMR reveals p53 core domain bound in an unfolded form to the chaperone Hsp90

被引:80
作者
Rüdiger, S
Freund, SMV
Veprintsev, DB
Fersht, AR
机构
[1] Univ Cambridge, Ctr Prot Engn, Cambridge CB2 2QH, England
[2] MRC Ctr, Cambridge CB2 2QH, England
关键词
molecular chaperones; transcription factors; protein folding;
D O I
10.1073/pnas.132393699
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The molecular chaperone Hsp90 sequesters oncogenic mutants of the tumor suppressor p53 that have unstable core domains. It is not known whether p53 is bound in an unfolded, partly folded, or distorted structure, as is unknown for the structure of any bound substrate of Hsp90. It is a particularly difficult problem to analyze in detail the structures of large complexes in which one component is (partly) unfolded. We have shown by transverse relaxation-optimized NMR spectroscopy combined with cross-correlated relaxation-enhanced polarization transfer (CRINEPT-TROSY) that p53 core domain bound in an approximate to200-kDa complex with Hsp90 was predominantly unfolded lacking helical or sheet secondary structure. This mode of binding might be a general feature of substrates of Hsp90.
引用
收藏
页码:11085 / 11090
页数:6
相关论文
共 28 条
[11]   Tumor-specific mutations in p53: The acid test [J].
Hainaut, P .
NATURE MEDICINE, 2002, 8 (01) :21-23
[12]   New approaches to understanding p53 gene tumor mutation spectra [J].
Hollstein, M ;
Hergenhahn, M ;
Yang, Q ;
Bartsch, H ;
Wang, ZQ ;
Hainaut, P .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1999, 431 (02) :199-209
[13]   TRANSIENT INTERACTION OF HSP90 WITH EARLY UNFOLDING INTERMEDIATES OF CITRATE SYNTHASE - IMPLICATIONS FOR HEAT-SHOCK IN-VIVO [J].
JAKOB, U ;
LILIE, H ;
MEYER, I ;
BUCHNER, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) :7288-7294
[14]   DT-diaphorase expression and tumor cell sensitivity to 17-allylamino,17-demethoxygeldanamycin, an inhibitor of heat shock protein 90 [J].
Kelland, LR ;
Sharp, SY ;
Rogers, PM ;
Myers, TG ;
Workman, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (22) :1940-1949
[15]   Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp9O interactions with wild-type or mutant p53 [J].
King, FW ;
Wawrzynow, A ;
Höhfeld, J ;
Zylicz, M .
EMBO JOURNAL, 2001, 20 (22) :6297-6305
[16]   NMR analysis of the binding of a rhodanese peptide to a minichaperone in solution [J].
Kobayashi, N ;
Freund, SMV ;
Chatellier, J ;
Zahn, R ;
Fersht, AR .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 292 (01) :181-190
[17]   Therapeutic exploitation of the p53 pathway [J].
Lane, DP ;
Lain, S .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) :S38-S42
[18]   Molecular chaperones: The busy life of Hsp90 [J].
Mayer, MP ;
Bukau, B .
CURRENT BIOLOGY, 1999, 9 (09) :R322-R325
[19]   How p53 binds DNA as a tetramer [J].
McLure, KG ;
Lee, PWK .
EMBO JOURNAL, 1998, 17 (12) :3342-3350
[20]   Hsp90 inhibitors as novel cancer chemotherapeutic agents [J].
Neckers, L .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) :S55-S61